Abstract
The prevalence of allergy and asthma has been increasing steadily in the developed world. Despite the growing health problems associated with these conditions few new therapeutic options are becoming available. Relatively recent developments have identified a role for proteases in promoting allergic sensitisation and allergic airway inflammation. It is also known that most major allergens have associated protease activity that is closely related to their efficacy to induce sensitization and inflammation. Here we review the evidence for the significance of protease activity in allergic airway disease and offer suggestions as to where the field could progress.
Keywords: Asthma, allergen, serine proteases, protease-activated receptors, allergic inflammation
Inflammation & Allergy - Drug Targets (Discontinued)
Title: Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?
Volume: 7 Issue: 4
Author(s): Harissios Vliagoftis and Paul Forsythe
Affiliation:
Keywords: Asthma, allergen, serine proteases, protease-activated receptors, allergic inflammation
Abstract: The prevalence of allergy and asthma has been increasing steadily in the developed world. Despite the growing health problems associated with these conditions few new therapeutic options are becoming available. Relatively recent developments have identified a role for proteases in promoting allergic sensitisation and allergic airway inflammation. It is also known that most major allergens have associated protease activity that is closely related to their efficacy to induce sensitization and inflammation. Here we review the evidence for the significance of protease activity in allergic airway disease and offer suggestions as to where the field could progress.
Export Options
About this article
Cite this article as:
Vliagoftis Harissios and Forsythe Paul, Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?, Inflammation & Allergy - Drug Targets (Discontinued) 2008; 7 (4) . https://dx.doi.org/10.2174/187152808786848379
DOI https://dx.doi.org/10.2174/187152808786848379 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins
Current Pharmaceutical Design Mouse Models of Asthma: Can They Give Us Mechanistic Insights into the Role of Nitric oxide?
Current Medicinal Chemistry Drugs Acting on Mast Cells Functions: A Cell Biological Perspective
Inflammation & Allergy - Drug Targets (Discontinued) The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Array-Comparative Genomic Hybridization Analysis of a Cohort of Saudi Patients with Epilepsy
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Chemoinformatics Models for Pharmaceutical Design, Part 2)
Current Pharmaceutical Design Bedside Lung Ultrasound in the Care of the Critically Ill
Current Respiratory Medicine Reviews Editorial: [Hot topic: Recent Advances in Drug Intolerance (Guest Editors: Jose A.G. Agundez)]
Current Drug Metabolism Immunomodulatory Properties of ES-62, a Phosphorylcholine - Containing Glycoprotein Secreted by Acanthocheilonema viteae
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Bacterial DNA in Inflammatory and Allergic Disease
Recent Patents on Inflammation & Allergy Drug Discovery A Miniaturized Glucocorticoid Receptor Translocation Assay Using Enzymatic Fragment Complementation Evaluated with qHTS
Combinatorial Chemistry & High Throughput Screening Training Pediatric Residents for Intervention on Tobacco
Current Pediatric Reviews Advances in Whole Genome Sequencing Technology
Current Pharmaceutical Biotechnology Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: New Targets for Structure-Based Drug Discovery)
Current Topics in Medicinal Chemistry Role of Metallothionein in Inflammatory Lung Diseases
Current Respiratory Medicine Reviews Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Current Drug Targets Eicosanoids in Prevention and Management of Diseases
Current Molecular Medicine Transient Receptor Potential A1 Modulators
Current Topics in Medicinal Chemistry